DrÀgerwerk, DE0005550636

The Oxylog 2000 plus from DrÀgerwerk AG & Co. KGaA - mobile ICU ventilation for rough days on the road

28.06.2026 - 08:34:59 | ad-hoc-news.de

The Oxylog 2000 plus keeps emergency teams supplied with controlled ventilation in ambulances and mobile intensive care, with an LCD, battery operation and support for invasive and non-invasive modes. This bestseller stays in focus for holders of DrÀgerwerk shares (ISIN DE0005550636).

DrÀgerwerk, DE0005550636
DrÀgerwerk, DE0005550636

Reviewed: ad hoc news Classics & Longseller desk. Edited and checked on 2026-06-28, 08:34. Details in the imprint.

The Oxylog 2000 plus from DrÀgerwerk AG & Co. KGaA sits on the wall of the ambulance, grey housing, bright LCD glow, fans humming while the vehicle shakes over potholes. Paramedics feel a steady, mechanical breathing behind them that makes the cabin sound almost like a small ICU.

What the ventilator offers

The Oxylog 2000 plus is a transport and emergency ventilator designed for pre-clinical and inter-hospital use, with pressure-controlled ventilation and support for both invasive and non-invasive modes. It runs on mains power or integrated battery, giving crews flexibility in unstable situations.

Its compact design allows mounting on stretchers, wall rails or bedside stands, while the front-facing connectors keep hoses and cables tidy in tight ambulance spaces. The LCD display shows airway pressure, tidal volume and alarms in a clean, high-contrast layout that remains readable even under harsh fluorescent lights.

How it feels in use

Emergency physicians often describe the Oxylog line as a kind of insurance policy: once the tube is placed, the ventilator delivers consistent breaths while the team focuses on circulation, medication and logistics. In the ambulance, the rhythmic hiss of gas and soft beep of alarms becomes a quiet soundtrack to every transfer.

The rotary knob interface means gloved hands can adjust respiratory rate, pressure and FiO2 without hunting for soft keys. Settings click into place with a tactile, reassuring resistance, which is welcome when the vehicle brakes hard or corners sharply.

Go deeper

Background on DrÀgerwerk shares

From ventilators like the Oxylog 2000 plus to full ICU solutions, DrĂ€gerwerk connects product demand in hospitals and rescue services with the long-run story in the company’s listed shares.

Modes, alarms and limits

The Oxylog 2000 plus typically offers pressure-controlled ventilation modes such as IPPV and CPAP, focusing on robust basic parameters rather than advanced lung-protective strategies reserved for high-end ICU devices. That simplicity can be practical in chaotic emergency scenarios, where quick parameter changes matter more than complex curves.

Alarm management focuses on high and low airway pressure, apnea, power supply and gas feed. Visual and acoustic signals are designed to be clearly heard over sirens and background noise, but not overwhelming for staff who spend hours in that acoustic environment.

Where it fits in DrĂ€ger’s range

Within the DrÀger portfolio, the Oxylog 2000 plus sits below more feature-rich transport systems and ICU ventilators such as Evita models that offer advanced volume and pressure modes, graphics and complex weaning support. For many ambulance services, the 2000 plus is the workhorse that covers most adult emergency scenarios with a tidy feature set.

In markets like India, dealers list the Oxylog 2000 plus with typical prices around 150,000 to 200,000 rupees per unit, targeting hospitals and ambulance fleets that need durable equipment and clear service channels. That price bracket places it in the mid-range of branded transport ventilators.

Human decisions behind the device

At DrÀgerwerk, CEO Stefan DrÀger has long positioned the company as a specialist in acute care technologies, linking devices like the Oxylog series to a broader ecosystem of monitors, anesthesia workstations and oxygen supply. His public statements repeatedly stress reliability and long product lifecycles as part of the brand identity.

Clinical engineers and anesthesiologists often influence purchasing decisions, comparing Oxylog ventilators with rival systems from other manufacturers. For them, service access, spare parts availability and training modules matter just as much as interface details or a clean housing design.

Stock context at the end

DrÀgerwerk shares (ISIN DE0005550636) are listed in Germany and trade on Xetra in euros, reflecting investor expectations around ongoing demand for ventilators like the Oxylog 2000 plus and adjacent hospital equipment.

Key facts on the Oxylog 2000 plus

  • Product: Oxylog 2000 plus
  • Manufacturer: DrĂ€gerwerk AG & Co. KGaA
  • Category: Classic emergency and transport ventilator
  • Launch: Introduced as part of the Oxylog transport ventilator family, designed for pre-clinical and inter-hospital use
  • RRP / Price: Often quoted around 150,000 to 200,000 INR per unit in dealer listings in India; pricing in Europe depends on configuration and service packages
  • Availability: Sold via medical equipment dealers and direct sales to hospitals and ambulance services in multiple regions, with a focus on professional users
  • Target group: Emergency medical services, intensive care units requiring transport ventilation, and hospital fleets managing inter-hospital transfers
  • Highlight / USP: Robust transport ventilator combining pressure-controlled modes, invasive and non-invasive support, and a compact, mountable form factor for demanding mobile environments

Find Oxylog ventilators online

Some configurations of the Oxylog 2000 plus appear in medical equipment listings that also surface via Amazon.de searches, mostly through specialist resellers.

Oxylog 2000 plus on Amazon

Affiliate link: ad-hoc-news.de earns a commission when you buy via this link. The price for you does not change.

Oxylog 2000 plus on social media

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

en | DE0005550636 | DRĂ€GERWERK | boerse | 69644370 | bgmi